Anderson JA - Search Results

1

Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study.

Jenkins CR, Celli B, Anderson JA, Ferguson GT, Jones PW, Vestbo J, Yates JC, Calverley PM. Jenkins CR, et al. Among authors: anderson ja. Eur Respir J. 2012 Jan;39(1):38-45. doi: 10.1183/09031936.00194610. Epub 2011 Jul 7. Eur Respir J. 2012. PMID: 21737561 Free article. Clinical Trial.

2

Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study.

Jenkins CR, Jones PW, Calverley PM, Celli B, Anderson JA, Ferguson GT, Yates JC, Willits LR, Vestbo J. Jenkins CR, et al. Among authors: anderson ja. Respir Res. 2009 Jun 30;10(1):59. doi: 10.1186/1465-9921-10-59. Respir Res. 2009. PMID: 19566934 Free PMC article. Clinical Trial.

3

Health status in the TORCH study of COPD: treatment efficacy and other determinants of change.

Jones PW, Anderson JA, Calverley PM, Celli BR, Ferguson GT, Jenkins C, Yates JC, Vestbo J, Spencer MD; TORCH investigators. Jones PW, et al. Among authors: anderson ja. Respir Res. 2011 May 31;12(1):71. doi: 10.1186/1465-9921-12-71. Respir Res. 2011. PMID: 21627828 Free PMC article. Clinical Trial.

4

The Study to Understand Mortality and Morbidity in COPD (SUMMIT) study protocol.

Vestbo J, Anderson J, Brook RD, Calverley PM, Celli BR, Crim C, Haumann B, Martinez FJ, Yates J, Newby DE. Vestbo J, et al. Eur Respir J. 2013 May;41(5):1017-22. doi: 10.1183/09031936.00087312. Epub 2012 Sep 27. Eur Respir J. 2013. PMID: 23018908 Free article. Clinical Trial.

5

Statistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE revisited.

Keene ON, Calverley PM, Jones PW, Vestbo J, Anderson JA. Keene ON, et al. Among authors: anderson ja. Eur Respir J. 2008 Jul;32(1):17-24. doi: 10.1183/09031936.00161507. Eur Respir J. 2008. PMID: 18591336 Free article.

6

Statistical analysis of COPD exacerbations.

Keene ON, Calverley PM, Jones PW, Vestbo J, Anderson JA. Keene ON, et al. Among authors: anderson ja. Eur Respir J. 2008 Nov;32(5):1421-2. doi: 10.1183/09031936.00123408. Eur Respir J. 2008. PMID: 18978151 Free article. No abstract available.

7

Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results.

Crim C, Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Willits LR, Yates JC, Vestbo J. Crim C, et al. Among authors: anderson ja. Eur Respir J. 2009 Sep;34(3):641-7. doi: 10.1183/09031936.00193908. Epub 2009 May 14. Eur Respir J. 2009. PMID: 19443528 Free article. Clinical Trial.

8

Methods for therapeutic trials in COPD: lessons from the TORCH trial.

Keene ON, Vestbo J, Anderson JA, Calverley PM, Celli B, Ferguson GT, Jenkins C, Jones PW. Keene ON, et al. Among authors: anderson ja. Eur Respir J. 2009 Nov;34(5):1018-23. doi: 10.1183/09031936.00122608. Eur Respir J. 2009. PMID: 19880616 Free article. Clinical Trial.

9

Bias due to withdrawal in long-term randomised trials in COPD: evidence from the TORCH study.

Vestbo J, Anderson JA, Calverley PM, Celli B, Ferguson GT, Jenkins C, Yates JC, Jones PW. Vestbo J, et al. Among authors: anderson ja. Clin Respir J. 2011 Jan;5(1):44-9. doi: 10.1111/j.1752-699X.2010.00198.x. Clin Respir J. 2011. PMID: 21159140

10

Gender does not influence the response to the combination of salmeterol and fluticasone propionate in COPD.

Vestbo J, Soriano JB, Anderson JA, Calverley P, Pauwels R, Jones P; TRISTAN Study Group. Vestbo J, et al. Among authors: anderson ja. Respir Med. 2004 Nov;98(11):1045-50. doi: 10.1016/j.rmed.2004.03.017. Respir Med. 2004. PMID: 15526804 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

972 results

Search Page

Filters